文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

3 欧盟克罗恩病诊断与管理循证共识 2016:第 1 部分:诊断与医学管理。

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.

机构信息

Fernando Gomollón, Professor of Medicine, Hospital Clínico Universitario "Lozano Blesa", Universidad de Zaragoza, IIS Aragón, CIBEREHD, Zaragoza, Spain.

Axel Dignass, Department of Medicine I, Agaplesion Markus Hospital, Willhelm-Epstein-Straße 4, 60431 Frankfurt/Main, Germany.

出版信息

J Crohns Colitis. 2017 Jan;11(1):3-25. doi: 10.1093/ecco-jcc/jjw168. Epub 2016 Sep 22.


DOI:10.1093/ecco-jcc/jjw168
PMID:27660341
Abstract

This paper is the first in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn's disease and concerns the methodology of the consensus process, and the classification, diagnosis and medical management of active and quiescent Crohn's disease. Surgical management as well as special situations including management of perianal Crohn's disease of this ECCO Consensus are covered in a subsequent second paper [Gionchetti et al JCC 2016].

摘要

本文是两篇系列出版物中的第一篇,内容涉及欧洲克罗恩病和结肠炎组织 [ECCO] 对克罗恩病的诊断和治疗的循证共识,涉及共识过程的方法学,以及活动期和缓解期克罗恩病的分类、诊断和医学管理。后续第二篇论文 [Gionchetti 等人,JCC 2016] 涵盖了手术管理以及包括肛门周围克罗恩病管理在内的特殊情况的 ECCO 共识。

相似文献

[1]
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.

J Crohns Colitis. 2016-9-22

[2]
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.

J Crohns Colitis. 2016-9-22

[3]
European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease.

J Crohns Colitis. 2016-8

[4]
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.

Endoscopy. 2009-7

[5]
European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Gut. 2006-3

[6]
Evolving roles of cross-sectional imaging in Crohn's disease.

Dig Liver Dis. 2016-9

[7]
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Gut. 2006-3

[8]
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.

J Crohns Colitis. 2020-2-10

[9]
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.

J Crohns Colitis. 2010-2

[10]
French national consensus clinical guidelines for the management of Crohn's disease.

Dig Liver Dis. 2017-4

引用本文的文献

[1]
The Role of Gut Microbiota in Gastrointestinal Immune Homeostasis and Inflammation: Implications for Inflammatory Bowel Disease.

Biomedicines. 2025-7-24

[2]
Targeted urinary metabolomics combined with machine learning to identify biomarkers related to central carbon metabolism for IBD.

Front Mol Biosci. 2025-8-11

[3]
Combined [F]-FDG PET-MR imaging for monitoring small bowel crohn's disease.

Eur J Nucl Med Mol Imaging. 2025-8-26

[4]
Exploring the multidimensional symptom experience in patients with inflammatory bowel disease-a contemporaneous network analysis.

Front Med (Lausanne). 2025-8-6

[5]
Lymphocyte Fractions as Indicators of T-Helper 1/T-Helper 2 Cytokine Profiles in Inflammatory Bowel Disease.

JGH Open. 2025-8-11

[6]
Development and validation of a novel model based on clinical characteristics to predict natural disease course progression in patients with stricturing Crohn's disease.

Therap Adv Gastroenterol. 2025-7-28

[7]
Pro-inflammatory and anti-inflammatory cytokines as candidate markers in the diagnosis and assessment of Crohn's disease activity.

Arch Med Sci. 2022-8-11

[8]
Correlation between radiomic features of Crohn's disease and secondary loss of response to infliximab.

World J Gastroenterol. 2025-7-21

[9]
Gut Hormones and Inflammatory Bowel Disease.

Biomolecules. 2025-7-14

[10]
A systematic review of vedolizumab in treating pediatric ulcerative colitis: efficacy and safety insights.

Therap Adv Gastroenterol. 2025-7-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索